Codiak BioSciences, Inc. Increase (Decrease) in Accounts Payable
Codiak BioSciences, Inc. reported Increase (Decrease) in Accounts Payable of $175.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2022-11-03
- Codiak BioSciences, Inc. increase (decrease) in accounts payable for the quarter ending 2022-09-30 was $825.00K, a 217.31% increase year-over-year.
- Codiak BioSciences, Inc. increase (decrease) in accounts payable for the quarter ending 2022-06-30 was -$385.00K.
- Codiak BioSciences, Inc. increase (decrease) in accounts payable for the quarter ending 2022-03-31 was -$265.00K, a 198.15% decline year-over-year.
- Codiak BioSciences, Inc. increase (decrease) in accounts payable for the quarter ending 2021-12-31 was -$110.00K.
- Codiak BioSciences, Inc. increase (decrease) in accounts payable for fiscal 2021 was $96.00K.
- Codiak BioSciences, Inc. increase (decrease) in accounts payable for fiscal 2020 was -$378.00K, a 125.77% decline from fiscal 2019.
- Codiak BioSciences, Inc. increase (decrease) in accounts payable for fiscal 2019 was $1.47M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2022-09-30 | $825.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $440.00K derived: sum of 2 quarters · filed 2022-11-03 | $175.00K 10-Q · filed 2022-11-03 | $65.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | -$385.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$650.00K 10-Q · filed 2022-08-04 | -$760.00K derived: sum of 3 quarters · filed 2022-08-04 | -$500.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | -$265.00K 10-Q · filed 2022-05-05 | -$375.00K derived: sum of 2 quarters · filed 2022-05-05 | -$115.00K derived: sum of 3 quarters · filed 2022-11-03 | -$439.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $150.00K derived: sum of 2 quarters · filed 2022-11-03 | -$174.00K derived: sum of 3 quarters · filed 2022-11-03 | $96.00K 10-K · filed 2022-03-10 |
| 2021-09-30 | $260.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$64.00K derived: sum of 2 quarters · filed 2022-11-03 | $206.00K 10-Q · filed 2022-11-03 | -$4.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$324.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$54.00K 10-Q · filed 2022-08-04 | -$264.00K derived: sum of 3 quarters · filed 2022-08-04 | -$392.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $270.00K 10-Q · filed 2022-05-05 | $60.00K derived: sum of 2 quarters · filed 2022-05-05 | -$68.00K derived: sum of 3 quarters · filed 2022-05-05 | $812.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$338.00K derived: sum of 2 quarters · filed 2022-03-10 | $542.00K derived: sum of 3 quarters · filed 2022-03-10 | -$378.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | -$128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $752.00K derived: sum of 2 quarters · filed 2021-11-04 | -$168.00K 10-Q · filed 2021-11-04 | $444.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $880.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$40.00K 10-Q · filed 2021-08-05 | $572.00K derived: sum of 3 quarters · filed 2021-08-05 | |
| 2020-03-31 | -$920.00K 10-Q · filed 2021-05-06 | -$308.00K derived: sum of 2 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $612.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $1.47M 10-K · filed 2021-03-17 | ||
| 2019-09-30 | $855.00K 10-Q · filed 2020-11-19 |